Press release
Global Artificial Intelligence (AI) in Remote Patient Monitoring Market to grow at a CAGR of 27.13% by 2032, Evaluates DelveInsight | Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofou
DelveInsight's "Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence (AI) in Remote Patient Monitoring companies actively working in the market.
To know more about why North America is leading the market growth in the Artificial Intelligence (AI) in Remote Patient Monitoring market, get a snapshot of the report Artificial Intelligence (AI) in Remote Patient Monitoring Market Trends
https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Artificial Intelligence (AI) in Remote Patient Monitoring Overview
Artificial Intelligence (AI) in Remote Patient Monitoring, also known as ear tubes or grommets, are small cylindrical devices inserted into the eardrum to allow air to enter the middle ear and prevent fluid buildup. They are commonly used to treat recurrent ear infections (otitis media) or persistent middle ear fluid (effusion) in children and adults. Artificial Intelligence (AI) in Remote Patient Monitoring help improve hearing, reduce the risk of infection, and relieve pressure or pain caused by fluid accumulation. The procedure to insert these tubes is called myringotomy and is typically quick and minimally invasive. The tubes often fall out on their own within 6 to 18 months.
DelveInsight Analysis: The AI in Remote Patient Monitoring market, valued at USD 1,926.51 million in 2024, is projected to grow at a compound annual growth rate (CAGR) of 27.13% from 2025 to 2032, reaching approximately USD 13,126.80 million by 2032.
Artificial Intelligence (AI) in Remote Patient Monitoring Market Insights
Geographically, North America is projected to lead the Artificial Intelligence (AI) in Remote Patient Monitoring market in 2024, holding the largest share among all regions. This leadership is driven by several factors, including the high incidence of middle ear infections, especially in children, which increases the demand for surgical solutions such as tympanostomy tube placement. The region's advanced healthcare infrastructure, broad access to modern surgical technologies, and the availability of skilled otolaryngologists further support device adoption. Moreover, rising awareness about ear health, proactive patient care practices, and favorable reimbursement policies contribute to the market's continued growth in North America.
To read more about the latest highlights related to Artificial Intelligence (AI) in Remote Patient Monitoring, get a snapshot of the key highlights entailed in the Artificial Intelligence (AI) in Remote Patient Monitoring
https://www.delveinsight.com/report-store/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Artificial Intelligence (AI) in Remote Patient Monitoring Market Report
• In September 2024, iRhythm Technologies announced that its zio® ECG monitoring system has received regulatory approval in Japan, marking the first AI-powered arrhythmia monitoring service to be introduced in the market.
• In April 2024, Royal Philips, a global health technology leader, announced a strategic alliance to integrate smartQare's innovative solution, viQtor, with Philips' industry-leading clinical patient monitoring systems. This partnership is set to deliver the next generation of continuous patient monitoring inside and outside the hospital, beginning in Europe.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Intelligence (AI) in Remote Patient Monitoring market during the forecast period
Key Players in the Artificial Intelligence (AI) in Remote Patient Monitoring Market
Some of the key market players operating in the Artificial Intelligence (AI) in Remote Patient Monitoring market include- Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat and others.
Which MedTech key players in the Artificial Intelligence (AI) in Remote Patient Monitoring market are set to emerge as the trendsetter explore @ Key Artificial Intelligence (AI) in Remote Patient Monitoring Companies
https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Artificial Intelligence (AI) in Remote Patient Monitoring Market Landscape
The increasing prevalence of diabetes and impaired glucose tolerance is fueling the demand for Artificial Intelligence (AI) in remote patient monitoring (RPM), as continuous monitoring and early intervention are crucial for effective disease control. AI-powered RPM devices assist healthcare providers in tracking glucose levels, identifying potential complications early, and creating personalized treatment strategies.
Additionally, the growing burden of chronic diseases such as cancer, cardiovascular disorders, and lifestyle-related conditions is expected to drive significant market growth from 2025 to 2032. This growth is further supported by the rising pace of product innovation, substantial global investments in digital health infrastructure, and a heightened focus on proactive, data-driven healthcare solutions.
However, the market's expansion faces certain challenges. Concerns around data privacy and security, stringent regulatory requirements, and the complexities involved in integrating AI technologies may hinder the widespread adoption of AI in remote patient monitoring in the coming years.
Scope of the Artificial Intelligence (AI) in Remote Patient Monitoring Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Product Type: Devices, Software, and Services
• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Application Type: Cancer, Cardiovascular Disorder, Lifestyle Disorders, and Others
• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By End-User: Hospitals and Clinics, Diagnostic Centers, and Homecare Setting
• Artificial Intelligence (AI) in Remote Patient Monitoring Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Intelligence (AI) in Remote Patient Monitoring Companies: Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofourmis, Optum, Inc., Headspace Health, Withings, NeuroRPM Inc., Caretaker Medical, Implicity, Stryker, Biobeat and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Artificial Intelligence (AI) in Remote Patient Monitoring market will grow by 2032? Click to get a snapshot of the Artificial Intelligence (AI) in Remote Patient Monitoring Market Analysis
https://www.delveinsight.com/sample-request/ai-in-remote-patient-monitoring-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Artificial Intelligence (AI) in Remote Patient Monitoring Market Report Introduction
2 Artificial Intelligence (AI) in Remote Patient Monitoring Market Executive summary
3 Regulatory and Patent Analysis
4 Artificial Intelligence (AI) in Remote Patient Monitoring Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Artificial Intelligence (AI) in Remote Patient Monitoring Market
7 Artificial Intelligence (AI) in Remote Patient Monitoring Market Layout
8 Global Company Share Analysis - Key Artificial Intelligence (AI) in Remote Patient Monitoring Companies
9 Company and Product Profiles
10 Project Approach
11 Artificial Intelligence (AI) in Remote Patient Monitoring Market Drivers
12 Artificial Intelligence (AI) in Remote Patient Monitoring Market Barriers
13 About DelveInsight
Latest Reports by DelveInsight
• Implantable Cardioverter Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Monkeypox Market: https://www.delveinsight.com/report-store/monkeypox-market
• Antibody Drug Conjugate Market: https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Tbi Market: https://www.delveinsight.com/report-store/traumatic-brain-injury-market
• Indwelling Catheters Market: https://www.delveinsight.com/report-store/indwelling-catheters-market
• Hyperlipidemia Market: https://www.delveinsight.com/report-store/hyperlipidemia-market
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Artificial Intelligence (AI) in Remote Patient Monitoring Market to grow at a CAGR of 27.13% by 2032, Evaluates DelveInsight | Medtronic, iRhythm Inc., Koninklijke Philips N.V., Siemens Healthineers, GE HealthCare, Apple Inc., alivecor Inc., Biofou here
News-ID: 4101639 • Views: …
More Releases from DelveInsight Business Research
Bardet-Biedl Syndrome Market Outlook 2034 - Clinical Trials, Market Size, Medica …
DelveInsight's recent publication, "Bardet-Biedl Syndrome Market Insight, Epidemiology, and Market Forecast - 2034," delivers an exhaustive examination of the evolving therapeutic and diagnostic landscape of this rare condition.
The report encompasses major markets, including the United States, the EU4 nations (Germany, France, Italy, Spain), the United Kingdom, and Japan. It highlights existing shortcomings in diagnostic capabilities and therapeutic options while providing insights into emerging strategies designed to improve management of Bardet-Biedl…
Global GM2 Gangliosidosis Clinical Trials 2025: Drug Pipeline, Regulatory Approv …
DelveInsight's "GM2 Gangliosidosis - Pipeline Insight, 2025" delivers an in-depth evaluation of the global research and development landscape, profiling both clinical and preclinical drug candidates with varied mechanisms of action. The report explores key advancements including AAV-based gene therapies focused on the central nervous system, innovations in delivery technologies, and novel approaches aimed at improving long-term safety and efficacy. It also examines shifting regulatory frameworks, biomarker-guided clinical trial designs, and…
Global Basal Cell Nevus Syndrome Clinical Trials 2025: Drug Pipeline, Regulatory …
DelveInsight's "Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025" provides an in-depth analysis of both current and forthcoming treatment options. The report covers therapies in clinical and preclinical stages, highlights innovative drug delivery technologies, and examines efforts to tailor treatments through genetic profiling. It also reviews regulatory advancements, rare disease designations, and key collaborations driving progress in this specialized yet critical area.
As the pipeline advances, a shift from managing…
Global Cerebral Amyloid Angiopathy Clinical Trials 2025: Drug Pipeline, Regulato …
DelveInsight's "Cerebral Amyloid Angiopathy Pipeline Insight, 2025" provides an in-depth analysis of the current and emerging therapeutic landscape for Cerebral Amyloid Angiopathy (CAA). The report comprehensively profiles ongoing clinical and preclinical development programs targeting disease modification, evaluates investigational imaging biomarkers to enhance early and accurate diagnosis, and examines regulatory frameworks alongside translational research initiatives that are accelerating drug development in this historically under-recognized cerebrovascular disorder.
With increasing awareness of Cerebral Amyloid…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
